Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (15) 15
cardiac & cardiovascular systems (13) 13
index medicus (13) 13
humans (11) 11
angioplasty (9) 9
cardiology and cardiovascular medicine (8) 8
male (8) 8
stents (8) 8
aged (7) 7
drug-coated balloon (7) 7
female (7) 7
paclitaxel (7) 7
peripheral artery disease (7) 7
restenosis (7) 7
femoropopliteal artery (6) 6
middle aged (6) 6
treatment outcome (6) 6
amputation (5) 5
coronary angiography (5) 5
lesions (5) 5
time factors (5) 5
drug-eluting balloon (4) 4
internal medicine (4) 4
ischemia (4) 4
mortality (4) 4
patients (4) 4
percutaneous transluminal angioplasty (4) 4
prospective studies (4) 4
abridged index medicus (3) 3
acute coronary syndromes (3) 3
acute myocardial-infarction (3) 3
aged, 80 and over (3) 3
cardiovascular agents - administration & dosage (3) 3
clopidogrel (3) 3
coated materials, biocompatible (3) 3
critical limb ischemia (3) 3
disease (3) 3
equipment design (3) 3
femoral artery (3) 3
femur (3) 3
heart attacks (3) 3
intervention (3) 3
medical imaging (3) 3
myocardial infarction - etiology (3) 3
outcomes (3) 3
paclitaxel - administration & dosage (3) 3
pain (3) 3
percutaneous coronary intervention - methods (3) 3
peripheral arterial disease (3) 3
peripheral vascular disease (3) 3
revascularization (3) 3
stenosis (3) 3
stroke - etiology (3) 3
target lesion revascularization (3) 3
trial (3) 3
acute coronary syndrome - surgery (2) 2
analysis (2) 2
angiography (2) 2
angioplasty, balloon - adverse effects (2) 2
angioplasty, balloon - instrumentation (2) 2
antithrombins - administration & dosage (2) 2
antithrombins - adverse effects (2) 2
artery-disease (2) 2
bleeding (2) 2
cardiac patients (2) 2
cardiology (2) 2
cardiovascular disease (2) 2
chronic total occlusions (2) 2
clinical trials (2) 2
coronary vessels (2) 2
drug-eluting stents (2) 2
electrocardiography (2) 2
europe (2) 2
heparin - administration & dosage (2) 2
heparin - adverse effects (2) 2
hirudins - administration & dosage (2) 2
hirudins - adverse effects (2) 2
implants (2) 2
italy (2) 2
laboratories (2) 2
limb salvage (2) 2
medical colleges (2) 2
medical research (2) 2
medical services (2) 2
medical treatment (2) 2
optical coherence tomography (2) 2
peptide fragments - administration & dosage (2) 2
peptide fragments - adverse effects (2) 2
percutaneous coronary intervention - adverse effects (2) 2
platelet aggregation inhibitors - administration & dosage (2) 2
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (2) 2
popliteal artery - physiopathology (2) 2
prosthesis design (2) 2
randomization (2) 2
randomized-trial (2) 2
recombinant proteins - administration & dosage (2) 2
recombinant proteins - adverse effects (2) 2
registries (2) 2
risk assessment (2) 2
risk factors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Working in the Mirror
by Castriota, Fausto, MD and Nerla, Roberto, MD and Squeri, Angelo, MD and Micari, Antonio, MD, PhD and Del Giglio, Mauro, MD and Cremonesi, Alberto, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 12, pp. e117 - e120
Cardiovascular | mirroring | dextrocardia | left atrial appendage closure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Vascular Scaffold for Below-the-Knee Vascular Disease
by Micari, Antonio, MD, PhD and Nerla, Roberto, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 16, pp. 1729 - 1730
Cardiovascular
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management
by Andò, Giuseppe, MD, PhD and Cortese, Bernardo, MD and Russo, Filippo, MD and Rothenbühler, Martina, MSc and Frigoli, Enrico, MD and Gargiulo, Giuseppe, MD and Briguori, Carlo, MD and Vranckx, Pascal, MD, PhD and Leonardi, Sergio, MD, MHS and Guiducci, Vincenzo, MD and Belloni, Flavia, MD and Ferrari, Fabio, MD and de la Torre Hernandez, Jose Maria, MD and Curello, Salvatore, MD and Liistro, Francesco, MD and Perkan, Andrea, MD and De Servi, Stefano, MD and Casu, Gavino, MD and Dellavalle, Antonio, MD and Fischetti, Dionigi, MD and Micari, Antonio, MD and Loi, Bruno, MD and Mangiacapra, Fabio, MD and Russo, Nunzio, MD and Tarantino, Fabio, MD and Saia, Francesco, MD, PhD and Heg, Dik, PhD and Windecker, Stephan, MD and Jüni, Peter, MD and Valgimigli, Marco, MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 21, pp. 2592 - 2603
Abstract Background It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI).... 
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text 2-Year Results of Paclitaxel-Eluting Balloons for Femoropopliteal Artery Disease
by Micari, Antonio, MD, PhD and Cioppa, Angelo, MD and Vadalà, Giuseppe, MD and Castriota, Fausto, MD and Liso, Armando, MD and Marchese, Alfredo, MD and Grattoni, Chiara, MD and Pantaleo, Paolo, MD and Cremonesi, Alberto, MD and Rubino, Paolo, MD and Biamino, Giancarlo, MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 3, pp. 282 - 289
Objectives This study aimed to appraise 2-year outcomes after percutaneous treatment of femoropopliteal artery disease with paclitaxel-eluting balloons.... 
Cardiovascular | percutaneous transluminal angioplasty | peripheral artery disease | drug-eluting balloon | angioplasty | Peripheral artery disease | Drug-eluting balloon | Percutaneous transluminal angioplasty | Angioplasty
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO)
by Latib, Azeem, MD and Ruparelia, Neil, MBBS, DPhil and Menozzi, Alberto, MD and Castriota, Fausto, MD and Micari, Antonio, MD and Cremonesi, Alberto, MD and De Felice, Francesco, MD and Marchese, Alfredo, MD and Tespili, Maurizio, MD and Presbitero, Patrizia, MD and Sgueglia, Gregory A., MD and Buffoli, Francesca, MD and Tamburino, Corrado, MD and Varbella, Ferdinando, MD and Colombo, Antonio, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 8, pp. 1132 - 1134
Cardiovascular | CORONARY | CARDIAC & CARDIOVASCULAR SYSTEMS | LESIONS | Predictive Value of Tests | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Cardiac Catheters | Coated Materials, Biocompatible | Equipment Design | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography | Coronary Artery Disease - therapy | Time Factors | Coronary Artery Disease - diagnosis | Italy | Paclitaxel - administration & dosage | Coronary Restenosis - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Transcatheter Aortic Valve-in-Valve Implantation Using Lotus Valve for Failed Surgical Bioprostheses
by Castriota, Fausto, MD and Nerla, Roberto, MD and Micari, Antonio, MD, PhD and Cavazza, Caterina, MD and Bedogni, Francesco, MD and Testa, Luca, MD and Montorfano, Matteo, MD and Del Giglio, Mauro, MD and Cremonesi, Alberto, MD
Annals of Thoracic Surgery, ISSN 0003-4975, 2017, Volume 104, Issue 2, pp. 638 - 644
Background Patients with failed bioprostheses are an increasing population at high risk for redo surgery. Valve-in-valve transcatheter aortic valve... 
Surgery | Cardiothoracic Surgery | REPLACEMENT | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-VALVES | DETERMINANTS | RESPIRATORY SYSTEM | EDWARDS SAPIEN | REGURGITATION | RISK | OUTCOMES | REOPERATION | FAILURE | Echocardiography, Transesophageal | Aortic Valve - diagnostic imaging | Follow-Up Studies | Risk Assessment | Heart Valve Prosthesis | Humans | Middle Aged | Risk Factors | Bioprosthesis - adverse effects | Male | Treatment Outcome | Aortic Valve Stenosis - diagnosis | Aortic Valve - surgery | Prosthesis Design | Prosthesis Failure | Time Factors | Aged, 80 and over | Adult | Female | Italy - epidemiology | Registries | Aged | Aortic Valve Stenosis - surgery | Transcatheter Aortic Valve Replacement - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease
by Micari, Antonio, MD, PhD and Nerla, Roberto, MD and Vadalà, Giuseppe, MD and Castriota, Fausto, MD and Grattoni, Chiara, MD and Liso, Armando, MD and Russo, Paolo, MD and Pantaleo, Paolo, MD and Roscitano, Giuseppe, MD and Cremonesi, Alberto, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 7, pp. 728 - 734
Abstract Objectives The aim of this study was to appraise 2-year outcomes after percutaneous transluminal angioplasty of long femoropopliteal artery disease... 
Cardiovascular | drug-eluting balloons | 24 months | long lesions | superficial femoral artery disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions
by Laird, John R., MD and Schneider, Peter A., MD and Tepe, Gunnar, MD and Brodmann, Marianne, MD and Zeller, Thomas, MD and Metzger, Christopher, MD and Krishnan, Prakash, MD and Scheinert, Dierk, MD and Micari, Antonio, MD, PhD and Cohen, David J., MD, MSc and Wang, Hong, MD, MPH and Hasenbank, Melissa S., PhD and Jaff, Michael R., DO
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 21, pp. 2329 - 2338
Abstract Background Evidence from large, randomized, controlled peripheral artery disease trials reporting long-term outcomes using drug-coated balloons (DCBs)... 
Cardiovascular | Internal Medicine | peripheral arterial disease | femoropopliteal artery | target lesion revascularization | angioplasty | Transluminal angioplasty | Health maintenance organizations | Sects | Medical colleges | Walking | Ultrasonic imaging | Medical imaging | Laboratories | Angioplasty | Amputation | Questionnaires | Cardiovascular disease | Stents | Thrombosis | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease
by Micari, Antonio, MD, PhD and Vadalà, Giuseppe, MD and Castriota, Fausto, MD and Liso, Armando, MD and Grattoni, Chiara, MD and Russo, Paolo, MD and Marchese, Alfredo, MD and Pantaleo, Paolo, MD and Roscitano, Giuseppe, MD and Cesana, Bruno Mario, MD and Cremonesi, Alberto, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 9, pp. 950 - 956
Abstract Objectives The aim of this study was to appraise 1-year outcomes after percutaneous treatment of long femoropopliteal artery disease using... 
Cardiovascular | paclitaxel-coated balloon | percutaneous transluminal angioplasty | peripheral artery disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels
by Latib, Azeem, MD and Colombo, Antonio, MD and Castriota, Fausto, MD and Micari, Antonio, MD and Cremonesi, Alberto, MD and De Felice, Francesco, MD and Marchese, Alfredo, MD and Tespili, Maurizio, MD and Presbitero, Patrizia, MD and Sgueglia, Gregory A., MD and Buffoli, Francesca, MD and Tamburino, Corrado, MD and Varbella, Ferdinando, MD and Menozzi, Alberto, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 24, pp. 2473 - 2480
Objectives The aim of this study was to evaluate the efficacy of drug-eluting balloons (DEB) compared with paclitaxel-eluting stents (PES) for the reduction of... 
Cardiovascular | Internal Medicine | paclitaxel | restenosis | revascularization | drug-eluting stent | drug-eluting balloon | late loss | Electrocardiography | Cardiology | Electrocardiogram | Stent (Surgery) | Paclitaxel | Heart attacks | Angioplasty | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia
by Zeller, Thomas, MD and Baumgartner, Iris, MD and Scheinert, Dierk, MD and Brodmann, Marianne, MD and Bosiers, Marc, MD and Micari, Antonio, MD, PhD and Peeters, Patrick, MD, PhD and Vermassen, Frank, MD, PhD and Landini, Mario, MS and Snead, David B., PhD and Kent, K. Craig, MD and Rocha-Singh, Krishna J., MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 15, pp. 1568 - 1576
Abstract Background Drug-eluting balloons (DEB) may reduce infrapopliteal restenosis and reintervention rates versus percutaneous transluminal angioplasty... 
Cardiovascular | Internal Medicine | drug-eluting balloon | peripheral vascular disease | critical limb ischemia | Transluminal angioplasty | Sects | Medical colleges | Ischemia | Stent (Surgery) | Standards | Wound healing | Angioplasty | Laboratories | Mortality | Amputation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Needing a Helping Hand
by Castriota, Fausto, MD and Nerla, Roberto, MD and Squeri, Angelo, MD and Micari, Antonio, MD, PhD and Del Giglio, Mauro, MD and Cremonesi, Alberto, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 9, pp. e91 - e93
Cardiovascular | challenging grasping | asymmetrical tethering | left Amplatz catheter | MitraClip
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text David Versus Goliath
by Micari, Antonio, MD, PhD and Vadalà, Giuseppe, MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 9, pp. 1057 - 1059
Cardiovascular
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of De Novo Lesions in the Superficial Femoral Artery
by Werner, Martin, MD and Micari, Antonio, MD, PhD and Cioppa, Angelo, MD and Vadalà, Giuseppe, MD and Schmidt, Andrej, MD and Sievert, Horst, MD and Rubino, Paolo, MD and Angelini, Annalisa, MD and Scheinert, Dierk, MD and Biamino, Giancarlo, MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 3, pp. 305 - 312
Objectives This study sought to evaluate the safety and performance of the Igaki-Tamai (Igaki Medical Planning Company, Kyoto, Japan) biodegradable stent in... 
Cardiovascular | Igaki-Tamai | peripheral artery disease | GAIA study | PLLA stent(s) | biodegradable stent | superficial femoral artery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease
by Micari, Antonio, MD, PhD and Cioppa, Angelo, MD and Vadalà, Giuseppe, MD and Castriota, Fausto, MD and Liso, Armando, MD and Marchese, Alfredo, MD and Grattoni, Chiara, MD and Pantaleo, Paolo, MD and Cremonesi, Alberto, MD and Rubino, Paolo, MD and Biamino, Giancarlo, MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 3, pp. 331 - 338
Objectives This study evaluated the use of a paclitaxel-eluting balloon (PEB) for treatment of femoropopliteal arterial disease. Background Conventional... 
Cardiovascular | restenosis | femoropopliteal artery | paclitaxel-eluting balloon(s) | ischemic vascular disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
by Valgimigli, Marco and Frigoli, Enrico and Leonardi, Sergio and Vranckx, Pascal and Rothenbühler, Martina and Tebaldi, Matteo and Varbella, Ferdinando and Calabrò, Paolo and Garducci, Stefano and Rubartelli, Paolo and Briguori, Carlo and Andó, Giuseppe and Ferrario, Maurizio and Limbruno, Ugo and Garbo, Roberto and Sganzerla, Paolo and Russo, Filippo and Nazzaro, Marco and Lupi, Alessandro and Cortese, Bernardo and Ausiello, Arturo and Ierna, Salvatore and Esposito, Giovanni and Ferrante, Giuseppe and Santarelli, Andrea and Sardella, Gennaro and de Cesare, Nicoletta and Tosi, Paolo and van 't Hof, Arnoud and Omerovic, Elmir and Brugaletta, Salvatore and Windecker, Stephan and Heg, Dik and Jüni, Peter and Campo, Gianluca and Uguccioni, Lucia and Tamburino, Corrado and Presbitero, Patrizia and Zavalloni-Parenti, Dennis and Ferrari, Fabio and Ceravolo, Roberto and Tarantino, Fabio and Pasquetto, Giampaolo and Casu, Gavino and Mameli, Stefano and Stochino, Maria Letizia and Mazzarotto, Pietro and Cremonesi, Alberto and Saia, Francesco and Saccone, Giovanni and Abate, Fabio and Picchi, Andrea and Violini, Roberto and Colangelo, Salvatore and Boccuzzi, Giacomo and Guiducci, Vincenzo and Vigna, Carlo and Zingarelli, Antonio and Gagnor, Andrea and Zaro, Tiziana and Tresoldi, Simone and Vandoni, Pietro and Contarini, Marco and Liso, Armando and Dellavalle, Antonio and Curello, Salvatore and Mangiacapra, Fabio and Evola, Rosario and Palmieri, Cataldo and Falcone, Camillo and Liistro, Francesco and Creaco, Manuela and Colombo, Antonio and Chieffo, Alaide and Perkan, Andrea and De Servi, Stefano and Fischetti, Dionigi and Rigattieri, Stefano and Sciahbasi, Alessandro and Pucci, Edoardo and Romagnoli, Enrico and Moretti, Luciano and Moretti, Claudio and De Caterina, Raffaele and Caputo, Marcello and Zimmarino, Marco and Bramucci, Ezio and Di Lorenzo, Emilio and Turturo, Maurizio and Bonmassari, Roberto and Penzo, Carlo and Loi, Bruno and Mauro, Ciro and Petronio, Anna Sonia and Gabrielli, Gabriele and Micari, Antonio and Belloni, Flavia and Amico, Francesco and Comeglio, Marco and Fresco, Claudio and ... and MATRIX Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 835 - 848
The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the... 
2017 ESC | SITE | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program
by Valgimigli, Marco, MD, PhD and MATRIX Investigators and MATRIX investigators
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 6, pp. 838 - 845.e6
Background Transradial intervention (TRI) and bivalirudin infusion compared with transfemoral coronary intervention or unfractionated heparin plus glycoprotein... 
Cardiovascular | BIVALIRUDIN | TRIAL | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PRIMARY PCI | INTERVENTION | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Female | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Radial Artery - surgery | Europe | Peptide Fragments - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Postoperative Hemorrhage - etiology | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Survival Analysis | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Femoral Artery - surgery | Percutaneous Coronary Intervention - adverse effects | Cardiac patients | Glycosaminoglycans | Intervention | Heart attacks | Medical imaging | Mortality | Cardiovascular disease | Clinical outcomes | Molecular weight | Studies | Pain | Ischemia | Coronary vessels | Electrocardiography | Acute coronary syndromes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon
by Schneider, Peter A and Laird, John R and Doros, Gheorghe and Gao, Qi and Ansel, Gary and Brodmann, Marianne and Micari, Antonio and Shishehbor, Mehdi H and Tepe, Gunnar and Zeller, Thomas
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2019, Volume 73, Issue 20, pp. 2550 - 2563
Background: Five years of prospective clinical trials confirm that the paclitaxel drug-coated balloon (DCB) (IN.PACT Admiral, Medtronic, Dublin, Ireland) is... 
femoropopliteal artery | drug-coated balloon | paclitaxel | ATHEROSCLEROTIC LESIONS | ELUTING STENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | POPLITEAL ARTERIES | FEMOROPOPLITEAL LESIONS | Mortality | Analysis | Paclitaxel | Medical equipment | Femur | Femoral artery | Medical services | Clinical trials | Drug delivery | Coatings | Randomization | Atherosclerosis | Implants | Amputation | Lesions | Stents | Drug dosages | Medical research | Cell survival | Medical treatment | Exposure | Survival | Patients | Meta-analysis | Studies | Arteriosclerosis | Balloons
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
by Schroë, Herman and Holden, Andrew H and Goueffic, Yann and Jansen, Shirley J and Peeters, Patrick and Keirse, Koen and Ito, Wulf and Vermassen, Frank and Micari, Antonio and Blessing, Erwin and Jaff, Michael R and Zeller, Thomas
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 02/2018, Volume 91, Issue 3, pp. 497 - 504
Objectives The purpose of this study was to assess the safety and performance of Stellarex Drug‐coated balloon (DCB). Background DCB coatings differ in... 
peripheral arterial disease | drug‐coated balloon | superficial femoral artery | drug-coated balloon | Prospective Studies | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Recovery of Function | Time Factors | Popliteal Artery - physiopathology | Female | Paclitaxel - administration & dosage | Cardiovascular Agents - administration & dosage | Limb Salvage | Femoral Artery - physiopathology | Treatment Outcome | Coated Materials, Biocompatible | Popliteal Artery - diagnostic imaging | Angioplasty, Balloon - instrumentation | Regional Blood Flow | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology |